首页> 美国卫生研究院文献>Blood >SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease
【2h】

SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease

机译:SAP基因转移可在X连锁淋巴增生性疾病的鼠模型中恢复细胞和体液免疫功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

X-linked lymphoproliferative disease (XLP1) arises from mutations in the gene encoding SLAM-associated protein (SAP) and leads to abnormalities of NKT-cell development, NK-cell cytotoxicity, and T-dependent humoral function. Curative treatment is limited to allogeneic hematopoietic stem cell (HSC) transplantation. We tested whether HSC gene therapy could correct the multilineage defects seen in SAP−/− mice. SAP−/− murine HSCs were transduced with lentiviral vectors containing either SAP or reporter gene before transplantation into irradiated recipients. NKT-cell development was significantly higher and NK-cell cytotoxicity restored to wild-type levels in mice receiving the SAP vector in comparison to control mice. Baseline immunoglobulin levels were significantly increased and T-dependent humoral responses to NP-CGG, including germinal center formation, were restored in SAP-transduced mice. We demonstrate for the first time that HSC gene transfer corrects the cellular and humoral defects in SAP−/− mice providing proof of concept for gene therapy in XLP1.
机译:X连锁淋巴组织增生性疾病(XLP1)由SLAM相关蛋白(SAP)编码基因的突变引起,并导致NKT细胞发育,NK细胞细胞毒性和T依赖性体液功能异常。治愈性治疗仅限于同种异体造血干细胞(HSC)移植。我们测试了HSC基因疗法是否可以纠正SAP -/-小鼠中出现的多谱系缺陷。用含有SAP或报道基因的慢病毒载体转导SAP -/-鼠HSC,然后再移植到受辐照的受体中。与对照小鼠相比,接受SAP载体的小鼠的NKT细胞发育明显更高,NK细胞的细胞毒性恢复至野生型水平。基线免疫球蛋白水平显着增加,并且在SAP转导的小鼠中恢复了对NP-CGG的T依赖性体液反应,包括生发中心的形成。我们首次证明,HSC基因转移可纠正SAP -/-小鼠中的细胞和体液缺陷,从而为XLP1中的基因治疗提供概念证明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号